BCL2L1 and acute myeloid leukemia: Finally, when we scrutinize an RNA-seq AML dataset from The Cancer Genome Atlas (TCGA)25, we find that low levels of RBM25 favor a relative high expression of the anti-apoptotic BCL2L1 isoforms (Fig. 5d).